Equinix — Jul 30, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001101239-25-000028
Showing in the filing
AFFO
“$3.703 and $3.783 billion”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 17
Adjusted EBITDA margin for FY2025
“49%”
Revenues for FY2025
“$9,233 - 9,333”
Adjusted EBITDA Margin % for Q3 FY2025
“49 - 50%”
AFFO per Share (Diluted) for FY2025
“$37.67 - 38.48”
Non-recurring Capital Expenditures (includes… for FY2025
“$3,520 - 4,000”
Recurring Capital Expenditures % of revenues for FY2025
“~3%”
Recurring Capital Expenditures % of revenues for Q3 FY2025
“3 - 4%”
Expected Cash Dividends for FY2025
“~$1,836”
Revenues for Q3 FY2025
“$2.314 and $2.334 billion”
Adjusted EBITDA for Q3 FY2025
“$1.139 and $1.159 billion”
Recurring capital expenditures for Q3 FY2025
“$70 and $90 million”
Total revenues for FY2025
“$9.233 and $9.333 billion”
Adjusted EBITDA for FY2025
“$4.517 and $4.597 billion”
AFFO for FY2025
“$3.703 and $3.783 billion”
Total capital expenditures for FY2025
“$3.792 and $4.292 billion”
Non-recurring capital expenditures for FY2025
“$3.520 and $4.000 billion”
Recurring capital expenditures for FY2025
“$272 and $292 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Adjusted EBITDA is expected to range between $4.517 and $4.597 billion, reflecting an adjusted EBITDA margin of 49%, an approximate 230 basis-point expansion over the previous year. This $46 million increase from previously issued guidance is mainly due to better-than-expected Q2 operating performance and foreign currency benefit when compared to prior guidance. AFFO is expected to range between $3.703 and $3.783 billion, an increase of 10 - 13% over the previous year on an as-reported basis or 10 - 12% on a normalized and constant currency basis. This $28 million 5 increase from previously issued guidance is mainly due to better-than-expected Q2 operating performance and foreign currency benefit when compared to prior guidance rates. AFFO per share is expected to range between $37.67 and $38.48, an 8 - 10% as-reported increase over the previous year, or 7 - 10% on a normalized and constant currency basis. Total capital expenditures are expected to range between $3.792 and $4.292 billion. This includes non-recurring capital expenditures of between $3.520 and $4.000 billion, which now incorporate approximately $450 million of on-balance-sheet xScale-related spend, which we expect to be reimbursed later this year as we transfer assets into our U.S. joint venture. Recurring capital expenditures are expected to range between $272 and $292 million. The U.S. dollar exchange rates used for 2025 guidance, taking into consideration the impact of our current foreign currency hedges, have been updated to $1.13 to the Euro, $1.29 to the British Pound, S$1.27 to the U.S. Dollar, ¥144 to the U.S. Dollar, A$1.52
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.